Purpose: To assess the feasibility of grading soft tissue sarcomas (STSs) using MRI features (radiomics). Materials and Methods: MRI (echo planar SE, 1.5T) from 19 patients with STSs and a known histological grading, were retrospectively analyzed. The apparent diffusion coefficient (ADC) maps, obtained by diffusion-weighted imaging acquisitions, were analyzed through 65 radiomic features, intensity-based (first order statistics, FOS) and texture (gray level co-occurrence matrix, GLCM; and gray level run length matrix, GLRLM) features. Feature selection (sequential forward floating search) and classification (k-nearest neighbor classifier) were performed to distinguish intermediate- from high-grade STSs. Classification was performed using th...
Soft Tissue Sarcomas (STS) are among the most dangerous diseases, with a 50% mortality rate...
Bone and soft-tissue primary malignant tumors or sarcomas are a large, diverse group of mesenchymal-...
Simple SummarySoft-tissue sarcomas constitute a rare cancer type, with approximately 40% of patients...
Purpose: To assess the feasibility of grading soft tissue sarcomas (STSs) using MRI features (radiom...
Background: Treatment decisions for multimodal therapy in soft tissue sarcoma (STS) patients greatly...
Purpose: To evaluate the usefulness of whole-tumor ADC histogram analysis based on entire tumor volu...
Objective: To assess the diagnostic performance of morphological MRI features separately and in com...
Radiomics extracts a large number of features from medical images to perform a quantitative characte...
Abstract Diffusion-weighted imaging (DWI) is proven useful to differentiate benign and malignant sof...
Purpose: Soft tissue sarcomas (STS) represent a heterogeneous group of diseases, and selection of in...
Simple Summary In soft-tissue sarcoma (STS) patients, the decision for the optimal treatment modalit...
Purpose: Soft tissue sarcomas (STS) represent a heterogeneous group of diseases, and selection of in...
Purpose: Soft tissue sarcomas (STS) represent a heterogeneous group of diseases, and selection of in...
Background: Size-based assessments are inaccurate indicators of tumor response in soft-tissue sarcom...
OBJECTIVES:To compare magnetic resonance imaging (MRI) parameters of small, deeply located non-malig...
Soft Tissue Sarcomas (STS) are among the most dangerous diseases, with a 50% mortality rate...
Bone and soft-tissue primary malignant tumors or sarcomas are a large, diverse group of mesenchymal-...
Simple SummarySoft-tissue sarcomas constitute a rare cancer type, with approximately 40% of patients...
Purpose: To assess the feasibility of grading soft tissue sarcomas (STSs) using MRI features (radiom...
Background: Treatment decisions for multimodal therapy in soft tissue sarcoma (STS) patients greatly...
Purpose: To evaluate the usefulness of whole-tumor ADC histogram analysis based on entire tumor volu...
Objective: To assess the diagnostic performance of morphological MRI features separately and in com...
Radiomics extracts a large number of features from medical images to perform a quantitative characte...
Abstract Diffusion-weighted imaging (DWI) is proven useful to differentiate benign and malignant sof...
Purpose: Soft tissue sarcomas (STS) represent a heterogeneous group of diseases, and selection of in...
Simple Summary In soft-tissue sarcoma (STS) patients, the decision for the optimal treatment modalit...
Purpose: Soft tissue sarcomas (STS) represent a heterogeneous group of diseases, and selection of in...
Purpose: Soft tissue sarcomas (STS) represent a heterogeneous group of diseases, and selection of in...
Background: Size-based assessments are inaccurate indicators of tumor response in soft-tissue sarcom...
OBJECTIVES:To compare magnetic resonance imaging (MRI) parameters of small, deeply located non-malig...
Soft Tissue Sarcomas (STS) are among the most dangerous diseases, with a 50% mortality rate...
Bone and soft-tissue primary malignant tumors or sarcomas are a large, diverse group of mesenchymal-...
Simple SummarySoft-tissue sarcomas constitute a rare cancer type, with approximately 40% of patients...